Stockreport

Enrollment underway in Jounce Therapeutics' early-stage JTX-8064 study in solid tumors [Seeking Alpha]

Jounce Therapeutics, Inc.  (JNCE) 
Last jounce therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.jouncetx.com
PDF Enrollment underway in Jounce Therapeutics' early-stage JTX-8064 study in solid tumors [Read more]